Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 23, 2006

View Archived Issues

Triterpenoids/rexinoid protect mice against lung and ER-negative breast cancer

Update on Exelixis oncology pipeline: Part II

Antiarthritic efficacy of GlcNBu shown in a rat model of inflammatory arthritis

Aeterna Zentaris: Q3 update

20-HETE inhibition has antiproliferative effects on renal cell carcinoma

Anti-ICOSL mAb shows promising results in experimental autoimmune glomerulonephritis

Phase I results show tocilizumab well tolerated, active in lupus

SALT-1 and SALT-2 show efficacy of tolvaptan in hyponatremia

Effects of MC-1 after CABG independent of aortic clamping time

Snapshots: New data from clinical studies of drug candidates for renal diseases

UCB's proposed takeover of Schwarz Pharma makes progress

Prana raises funds to conduct phase IIa study of PBT-2 in early Alzheimer's

PARI and Kamada collaborate on development of inhaled alpha-1 antitrypsin

Clearance for first clinical study of BF-1 for prophylaxis of severe migraine

Orphan drug designation for RG-1068 for MRI of the pancreas

Pafuramidine awarded orphan drug designation for PCP

MultiCell's drug candidate shows potential to treat virally induced cancers

Green Cross granted Korean license to OP-145 for chronic otitis media

Roche to discontinue codevelopment of daclizumab for transplant maintenance

Sosei discontinues development of AD-452 for RA based on phase IIb results

Vascular targeted phototherapy with Tookad shows promise in prostate cancer

Snapshots of recent studies of bevacizumab on AMD and related conditions

orBec NDA accepted for review

Fast track designation for Bronchitol in cystic fibrosis

Keppra recommended in E.U. for new epilepsy indication

Recent Vertex and Pfizer patents report novel analgesic agents

Novel antiinfective agents disclosed in recent patent literature

Recent Pfizer and Roche patents report novel therapeutic agents for HCV infection

Emerging companies showcased at BIO-Europe 2006: Aegera Therapeutics

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 11, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...